Ana Sayfa Davet Kayıt Kurslar Program Bildiri
TR EN
color-splash

Abstract

Please review the guidelines below before submitting your abstract to SeENS 2026.

IRIS Abstract Submission

Submit Abstract 

Final deadline: October 30, 2026 

SeENS 2026 Abstract Awards

 

*The submission deadline for abstracts to be presented as part of the "Neurovascular Symposium" program has been extended to October 30, 2026.

 

*If you would like your abstract to be included in the “Neurovascular Symposium” program, please submit your abstract in Turkish by selecting the Neurovascular Surgery category. If you would like your abstract to be included in the “Seens Congress” program, you may submit your abstract in English by selecting your preferred category.

 

Points to Consider

Please ensure your abstract meets the format and content requirements.

  • Use the following sections: Title, Objective, Methods, Results, and Conclusions (each entered in its corresponding field).
  • Title must not exceed 200 characters (including spaces). Abstract text must not exceed 3000 characters (including spaces).
  • Objective: reason for the study. Methods: participants/cases and methods. Results: data and statistics if applicable. Conclusions: outcomes and contribution to knowledge.
  • Do not include any information that identifies authors or institutional affiliations in the title or main text.
  • Define abbreviations in full at first occurrence.

Peer Review Criteria

Paying attention to these points may increase the likelihood of acceptance.

  • Objective is valid, meaningful, and clearly stated.
  • Number of cases/participants is sufficient.
  • Methodology is clearly described and reproducible.
  • For clinical studies: prospective design, control group, and adequate follow-up.
  • Results are clear and understandable.
  • Statistical analyses have been performed (where appropriate).
  • Data are interpreted correctly.
  • Conclusions are appropriate and meaningful.
  • Study provides new knowledge or perspectives.

Technical Support

For submission issues, please contact: